Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-06-12
1991-03-19
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514946, 514947, 424449, A61K 3100, A61K 3144, A61F 1300
Patent
active
050011391
ABSTRACT:
The transdermal flux rates of 1,4-dihydropyridine derivatives, such as nilvapidine and its enantiomers may be increased by the use of a solvent vehicle which comprises dioctyl adipate, isopropyl myristate, benzyl alcohol, diisopropyl adipate, a mixture of 5 to 50% ethyl alcohol and 95-50% of diisopropyl adipate, or a mixture of any of the foregoing.
REFERENCES:
patent: 4284634 (1981-08-01), Satu
patent: 4338322 (1982-07-01), Satu
patent: 4537898 (1985-08-01), Hoff et al.
patent: 4685911 (1987-08-01), Konno et al.
Patent Abstracts of JP-vol. 10, No. 166 (C-353) (2222), 13th Jun. 1986; and JP-A- 61 18717 (Nichiban).
Lawter James R.
Pawelchak John M.
American Cyanamid Company
Lee Lester L.
Pili-Curtis Carmen
Szatkowski Thomas S.
LandOfFree
Enchancers for the transdermal flux of nivadipine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enchancers for the transdermal flux of nivadipine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enchancers for the transdermal flux of nivadipine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010301